Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Jeffery Alan Zablocki"'
Autor:
Joseph C. Loftus, Jeffrey W. Smith, Jeffery Alan Zablocki, Carol Halloran, Larry P. Feigen, Mark H. Ginsberg
Publikováno v:
Journal of Biological Chemistry. 271:2033-2039
The integrin alpha subunits play a major role in the regulation of ligand binding specificity. To gain further insight into the regions of the alpha subunits that regulate ligand specificity, we have utilized alpha v / alpha IIb chimeras to identify
Autor:
Jeffery Alan Zablocki, Neal F. Haas, Anita K. Salyers, S.G. Panzer-Knodle, Beatrice B. Taite, Larry P. Feigen, Marc Herin, Kay Broschat, Lucy W. King, Phillipe Jacqmin, Bradley T. Keller, V. Wayne Engleman, Nancy S. Nicholson, James A. Szalony
Publikováno v:
Circulation. 91:403-410
Background Intravenous therapy has been shown to be beneficial in the prevention of acute platelet-associated thrombotic events. However, orally active agents would be advantageous for chronic therapy. Fibrinogen receptor antagonists block the fibrin
Autor:
Dudley E. McMackins, Mihaly V. Toth, Henry E. Dayringer, J. G. Rico, P. R. Bovy, Nancy S. Nicholson, Anita K. Salyers, Beatrice B. Taite, Jeffery Alan Zablocki, Larry P. Feigen, Thomas E. Rogers, Shashidhar N. Rao, Mark E. Zupec, Robert Bruce Garland, Steven Paul Adams, M. Herin, R. J. Lindmark, Foe S. Tjoeng, S.G. Panzer-Knodle, Masateru Miyano
Publikováno v:
Bioorganic & Medicinal Chemistry. 2:881-895
The evolutionary process from the Arg-Gly-Asp-Phe (RGDF) tetrapeptide to potent orally active anti-platelet agents is presented. The RGD sequence is an important component in the recognition of fibrinogen by its platelet receptor GP IIb-IIIa (integri
Publikováno v:
Expert Opinion on Investigational Drugs. 3:437-448
Fibrinogen receptor antagonists represent a potential new form of antithrombotic therapy for the treatment or prevention of vascular complications including: myocardial infarct, unstable angina, stroke and complications during percutaneous translumin
Autor:
Nancy S. Nicholson, Jeffery Alan Zablocki, R. J. Lindmark, D Pireh, Robert Bruce Garland, Beatrice B. Taite, Masateru Miyano, Shashidhar N. Rao, L Schretzman, S.G. Panzer-Knodle
Publikováno v:
Journal of Medicinal Chemistry. 36:1811-1819
Peptide mimetics of the RGDF sequence in which Arg-Gly has been replaced with 5-(4-amidinophenyl)pentanoyl mimetic has led to a 1000-fold increase in inhibitory potency over the natural RGDF ligand. The guanidine residue of the arginine may be involv
Autor:
Larry P. Feigen, S.G. Panzer-Knodle, P. Jacqmin, V. W. Engleman, J. D. Page, Nancy S. Nicholson, Jeffery Alan Zablocki
Publikováno v:
Platelets. 6(5)
In order to compare binding of small peptide mimetics on activated vs resting platelets and with fibrinogen (fgn) on activated platelets, the binding of [(3)H]-SC-52012, a low molecular weight (483) mimetic of the RGDF sequence present in fgn, was ev
Autor:
S. G. Panzer-Knodle, Anita K. Salyers, Jeffery Alan Zablocki, Nancy S. Nicholson, Mihaly V. Toth, F. S. Tjoeng, Beatrice B. Taite, Larry P. Feigen
Publikováno v:
Peptides 1994 ISBN: 9789072199218
Peptides 1994
Peptides 1994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efc4a84a1d002cddfb2f1537c91fdccf
https://doi.org/10.1007/978-94-011-1468-4_327
https://doi.org/10.1007/978-94-011-1468-4_327
Autor:
D. E. Mcmackins, Nancy S. Nicholson, Jeffery Alan Zablocki, Thomas E. Rogers, Mihaly V. Toth, Steven Paul Adams, Beatrice B. Taite, Anita K. Salyers, M. Miyano, M. E. Zupec, R. B. Garland, R. J. Lindmark, F. S. Tjoeng, Larry P. Feigen, P. R. Bovy, J. G. Rico, S G Panzer-Knodle
Publikováno v:
Peptides ISBN: 9789401042956
Peptides
Peptides
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dad2aa1184fb4053127c0246eabcc23b
https://doi.org/10.1007/978-94-011-0683-2_101
https://doi.org/10.1007/978-94-011-0683-2_101
Autor:
Larry P. Feigen, Nancy S. Nicholson, S.G. Panzer-Knodle, Shashidhar N. Rao, Jeffery Alan Zablocki, Masateru Miyano
Publikováno v:
Journal of medicinal chemistry. 35(26)
Publikováno v:
Transfusion Science. 15:iv
Novel substituted β amino acid derivatives are provided which inhibit platelet aggregation and intermediates thereof. This invention also pertains to pharmaceutical compositions and methods of using such derivatives.